Frequently Asked Questions

What is the current status of the trial?
The trial is now enrolling at numerous sites around the United States. To get the latest updates and sign up for our weekly Q&A webinars, visit our news page.

What are the eligibility criteria?
The inclusion and exclusion criteria of the HEALEY ALS Platform Trial can be found on clinicaltrials.gov.

How do I enroll in the trial?
If you are interested in participating in the trial, please contact the research coordinator at the site that would be most convenient for you- specific factors affecting your participation might be discussed with the research coordinator. Contact information can be found on clinicaltrials.gov and on our locations listing here.

If you are having difficulties identifying the site and coordinator or if you have any additional questions or concerns, please email HEALEYALSPlatform@mgh.harvard.edu or call 833-425-8257 (HALT ALS).

What drugs/therapies are being tested in the Platform Trial?
We plan on testing several potential therapies. We have already selected the first five potential therpaies and are aleady working on adding more over the next few months. Currently, we are randomizing patients to one of the first three potential therapies and expect the fourth to be included in the Platform Trial soon.